APAS® INDEPENDENCE RECEIVES US FDA 510(k) CLEARANCE
Regulatory clearance of commercial instrument provides access to over 1,500 U.S. laboratories as potential customers Investor call at 9.00am AEST, Tuesday 21 May 2019 to discuss FDA clearance and U.S. market opportunity Adelaide, Australia, 20th May 2019: Australian…
Read MoreVCCC Investigator-Initiated Trial Building Capability Program: Clinical trials target common symptoms
Monday 20 May 2019 Cancer clinical trials predominantly focus on new therapies to control cancer. However, patients with cancer commonly experience symptoms not directly related to the cancer itself. These symptoms can have a significant impact on the…
Read MoreMedTech Actuator Announces Collaboration with Johnson & Johnson Innovation to Support Health Tech Startups in Victoria
13 May 2019 A new collaboration is set to strengthen Australia and the Asia Pacific’s innovation ecosystem. The MedTech Actuator has teamed up with Johnson & Johnson Medical Pty Ltd, one of the Johnson & Johnson Medical Devices…
Read MoreMedia Release: Joint industry pre-election statement on health research and development
9 May 2019 Industry is a key driver of better health outcomes in our health system, and industry-driven research and development (R&D) activities are critical to achieve this. Creating a business environment that better supports emerging and cutting-edge…
Read MoreArticles on Cloud Computing & Privacy and Data Protection – provided by Stephens Lawyers & Consultants
Below are some articles shared with our members by Stephens Lawyers & Consultants: “Cloud Computing – Understanding and Managing the Risks” The link Is:- https://www.stephens.com.au/cloud-computing-information-sheet/ “Privacy and Data Protection – Risk Management: Data Protection and Privacy…
Read More
